Global Infectious Disease Diagnostics Market is estimated to be valued at US$ 1,451.5 Mn in 2023 and is expected to exhibit a CAGR of 9.81% during the forecast period (2023-2030). Infectious Diseases are caused by pathogens such as bacteria, virus, fungi or parasites. Infectious disease spreads from one person to other either through direct contact or indirectly through insect bites or through other vectors like food, soil, water, and air. Diagnosis means the identification of disease causing agents, by studying the symptoms exhibited by the afflicted individual. This plays a vital role in making decisions regarding treatment of infectious and other diseases.
Analysts’ Views on Infectious Disease Diagnostics Market:
Increasing prevalence of infectious disease and rising Research and development activity on infectious disease diagnostics are important drivers for market expansion. For instance, according to an article published by Frontiers, in February 2022, non- typhoid Salmonella is a common cause of bacterial enteritis in human, almost 93.8 million cases of gastroenteritis is reported globally each year.
Figure 1. Global Infectious Disease Diagnostics Market, By Technology, 2023
Global Infectious Disease Diagnostics Market- Drivers
Increasing Prevalence of Infectious Disease
Increasing prevalence of infectious diseases is expected to propel growth of the global infectious disease diagnostics market over the forecast period. For instance, till February 23, 2020, 76,936 cases were reported in China and 1,875 cases of coronavirus disease2019 were reported in locations outside China and the number of associated deaths with Covid-19 was 2,462.For instance , according to WHO A total of 1.6 million people died from Tuberculosis in 2021 (including 187 000 people with HIV). Worldwide, TB is the 13th leading cause of death and the second leading infectious killer after COVID-19 (above HIV/AIDS). North America held a dominant position in the global infectious disease diagnostics market, accounting for 38.2% share, in terms of value, followed by Europe.
Infectious Disease Diagnostics Market Report Coverage
|Base Year:||2022||Market Size in 2023:||US$ 1,451.5 Mn|
|Historical Data for:||2017 to 2021||Forecast Period:||2023 to 2030|
|Forecast Period 2023 to 2030 CAGR:||9.81%||2030 Value Projection:||US$ 2,794.4 Mn|
Becton Dickinson & Company , Cepheid, Inc, Abbott Laboratories, BioMerieux SA, Hologic, Inc, Danaher Corporation, Thermo Fisher Scientific, Inc, Roche Diagnostics, DiaSorin S.p.A, Quidel Corporation, Bio-Rad Laboratories,.
|Restraints & Challenges:||
Availability of Various Diagnostic Tests
Diagnostic sector is one of the sector with very less innovation of new updated technology. In the year 2022 different types of Diagnostic tests were innovated to satisfy the need of the people. Multiple test made available in North America , Latin America, Europe, Asia Pacific, Middle East, Africa region. This included Self-Testing and Artificial Intelligence. Artificial intelligence techniques to diagnose numerous diseases such as Alzheimer, cancer, diabetes, chronic heart disease, tuberculosis, stroke and cerebrovascular, hypertension, skin, and liver disease.
Figure 2. Global Infectious Disease Diagnostics Market Share (%), By Region, 2023
Global Infectious Disease Diagnostics Market- Regional Analysis
Among region, North America is expected to dominate the market over the forecast period, due to increasing prevalence of Infectious disease diagnostics market in the region. For instance, In Aug 2021, Australian researchers at the Kirby Institute at UNSW Sydney, Burnet Institute, and Doherty Institute, along with international organizations, the Clinton Health Access Initiative and Foundation for Innovative New Diagnostics, have received US $5.2 million to improve laboratory capacity for testing and diagnosis of COVID-19, HIV, malaria, and tuberculosis in the Indo-Pacific region.
Infectious Disease Diagnostics Market- Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic had a positive impact on the global infectious disease diagnostics market, due to increasing participation of the people in infectious disease diagnosis. Fortress Diagnostics, in July 2021, launched a rapid test that helps in detecting various infections. This includes Influenza A, Influenza B, and COVID-19, by using a nasal swab. These tests are approved by scientists of Porton Down, Science Park England. This tests will help the practitioner to get the results within 15 minutes. These testing is done rapidly and it is also affordable. Hence, a lot of people are purchasing this test and eventually it helps to grow the market.
Global Infectious Disease Diagnostics Market Segmentation:
The Infectious Disease Diagnostics Market report is segmented into, Technology, Disease, End User, and Region.
Based on technology, the global infectious disease diagnostics market is divided into: ELISA, Polymerase Chain Reaction (PCR), Immunoassays, Cell Cultures and Others. Among all these technology, In 2021, PCR is the dominated segment, as PCR technology provides quick results as compare to others. The demand for PCR in infectious disease diagnostics is rising, as a result of the rapid identification of bacteremia by PCR.
Based on disease indication, the global infectious disease diagnostics market is segmented into: CNS Infection, Diarrheal Disease, Respiratory Infections, Blood Infection, STDs. According to the U.S. Center for Disease Control and Prevention, nearly 1.7 million hospitalized patients annually acquires Health care-associated infections (HCAIs) while being treated for other health issues and that more than 98,000 of these patients (one in 17) die due to Health care-associated infections (HCAIs).
Based on End User, Global Infectious Disease Diagnostics Market is segmented into hospitals, ambulatory surgical centers, dermatology clinics, and others (Research Institutes, Specialty Centers, etc ). Hospitals segment is expected to dominate the market over the forecast period. For instance, In March 2022 according to WHO, out of every 100 patients 7 in high and 15 in low-/middle-income countries (LMIC) acquires at least one Hospital care Associate Infection (HAI), in acute care hospitals globally.
Based on Region, Infectious Disease Diagnostics Market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the market over the forecast period, due to increasing number of product approvals from regulatory authorities. For instance, in April 2021, the government of Canada formed five multidisciplinary infectious disease modelling networks with a total expenditure of USD 10 million. The findings will enable Canada to better respond to potential threats to public health, which will spur the industry to expand. The coordination of infectious disease modelling will also be considerably improved.
Global Infectious Disease Diagnostics Market - Cross Sectional Analysis:
In global infectious disease diagnostics market, North America emerged as a dominant regional market with share accounting for 36.5%. Well-developed health care system is likely to boost the growth of market in region. Due to increasing prevalence rate of the infectious disease, there are large number of clinics available. In 2020, a total of 1,579,885 cases of Chlamydia trachomatis infection were reported to the Centers for Disease Control and Prevention (CDC), making it the most common notifiable sexually transmitted infection in the United States for that year.
Global Infectious Disease Diagnostics Market: Key Developments
Global Infectious Disease Diagnostics market: Restraint
High price of molecular-based test kits is expected to hinder growth of the market. Molecular-based test kits plays a major part in the diagnosis of infectious disease. However, the high price of molecular test kits is leading to its low adoption, especially in US and Europe countries. Lack of reimbursement for certain infectious diseases is also expected to limit growth of the market. For instance, in July 2018, the Centers for Medicare & Medicaid Services significantly reduced the reimbursement for evaluation and management of complex cases, such as those suffering from infectious disease.
Global Infectious Disease Diagnostics Market: Opportunities
Introduction of cost-effective and reliable test kits is expected to offer lucrative growth opportunities to players in the market. Currently, very few effective diagnostic test kits are available for infectious diseases. Unavailability of effective diagnostic tools and high prices of existing test kits has triggered the need for cost-effective test kits with high- specificity and sensitivity.
Moreover, R&D in diagnostic kits is also expected to aid in growth of the market. For instance, in September 2019, researchers from University of Helsinki, Finland, reported that the antibody response against Puumala orthohanta virus can be measured at a high- sensitivity and specificity with the unorthodox point-of-care assay LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection, using urine as sample matrix.
Global Infectious Disease Diagnostics Market: Competitive Landscape
Major players operating in the global infectious disease diagnostics market include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Definition: Infectious diseases are disorders caused by organisms — such as bacteria, viruses, fungi or parasites. Infectious diseases are diagnosed by detection of a bacterium, virus, fungus, protozoan, or helminth in a patient with a compatible clinical illness. Many organisms live in and on our bodies. They're normally harmless or even helpful. But under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person.
Frequently Asked Questions